Recent insider buying activity highlights significant movements within the Vanguard Health Care ETF (VHT), where 16.3% of holdings have reported insider purchases in the past six months. Clover Health Investments Corp (CLOV) has seen two directors buy shares, contributing to the ETF’s investment of $3,319,942 in CLOV, representing 0.02% of total holdings. The latest insider purchases include 446,980 shares bought by Director Vivek Garipalli on August 8, 2025, at a price of $2.23 per share, totaling approximately $999,000.
Similarly, Tandem Diabetes Care Inc (TNDM), ranked as the 216th largest holding within the VHT, has also experienced insider purchases from two directors. The ETF holds $4,291,361 worth of TNDM, also about 0.02% of its total assets. Notably, EVP & CFO Leigh Vosseller purchased 13,720 shares on August 8, 2025, at $10.89 per share, amounting to roughly $149,404, while President & CEO John F. Sheridan acquired 10,000 shares on August 11, 2025, at $10.23 per share, totaling approximately $102,318.
